Vanguard Group Inc Anavex Life Sciences Corp. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Vanguard Group Inc holds 4,902,246 shares of AVXL stock, worth $36.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,902,246

Previous 4,680,444 4.74%

Holding current value

$36.9 Million

Previous $50.3 Million 16.32%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$7.85 - $13.46 $1.74 Million - $2.99 Million	221,802 Added 4.74%	4,902,246 $42.1 Million
Q4 2024 Feb 11, 2025	SELL	$5.11 - $12.56 $305,204 - $750,171	-59,727 Reduced 1.26%	4,680,444 $50.3 Million
Q3 2024 Nov 13, 2024	BUY	$4.11 - $7.04 $788,922 - $1.35 Million	191,952 Added 4.22%	4,740,171 $26.9 Million
Q2 2024 Aug 13, 2024	BUY	$3.39 - $5.02 $452,690 - $670,355	133,537 Added 3.02%	4,548,219 $19.2 Million
Q1 2024 May 10, 2024	BUY	$4.55 - $6.75 $245,854 - $364,729	54,034 Added 1.24%	4,414,682 $22.5 Million
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $581,132 - $1.15 Million	115,304 Added 2.72%	4,360,648 $40.6 Million
Q3 2023 Nov 14, 2023	BUY	$6.55 - $9.37 $269,814 - $385,978	41,193 Added 0.98%	4,245,344 $27.8 Million
Q2 2023 Aug 14, 2023	BUY	$7.66 - $9.5 $256,970 - $318,696	33,547 Added 0.8%	4,204,151 $34.2 Million
Q1 2023 May 15, 2023	BUY	$8.32 - $11.75 $217,185 - $306,722	26,104 Added 0.63%	4,170,604 $35.7 Million
Q4 2022 Feb 10, 2023	BUY	$7.65 - $14.43 $294,563 - $555,627	38,505 Added 0.94%	4,144,500 $38.4 Million
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $1.07 Million - $1.54 Million	119,684 Added 3.0%	4,105,995 $42.4 Million
Q2 2022 Aug 12, 2022	BUY	$7.31 - $12.84 $744,669 - $1.31 Million	101,870 Added 2.62%	3,986,311 $39.9 Million
Q1 2022 May 13, 2022	BUY	$9.74 - $17.69 $417,563 - $758,387	42,871 Added 1.12%	3,884,441 $47.8 Million
Q4 2021 Feb 14, 2022	SELL	$16.88 - $23.31 $2.53 Million - $3.49 Million	-149,802 Reduced 3.75%	3,841,570 $66.6 Million
Q3 2021 Nov 12, 2021	BUY	$16.82 - $25.75 $5.78 Million - $8.84 Million	343,379 Added 9.41%	3,991,372 $71.6 Million
Q2 2021 Aug 13, 2021	BUY	$10.16 - $28.86 $37.1 Million - $105 Million	3,647,993 New	3,647,993 $83.4 Million

Others Institutions Holding AVXL

# of Institutions

203

Shares Held

31M

Call Options Held

1.3M

Put Options Held

662K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $587M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Anavex Life Sciences Corp. Transaction History